secwatch.observer — SEC 8-K summary
======================================

Issuer:     Estrella Immunopharma, Inc. (ESLA)
CIK:        0001844417
Form:       8-K
Filed at:   2024-12-16T23:59:59+00:00
Accession:  0001213900-24-109285
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Estrella Immunopharma regains compliance with both Nasdaq listing requirements
------------------------------------------------------------------------------

- Regained compliance with Stockholders' Equity Requirement after market value of listed securities exceeded $35M for 10 consecutive days ending Dec 10, 2024.
- Regained compliance with Minimum Bid Price Requirement after closing bid price of common stock stayed at $1.00+ for 10 consecutive days ending Dec 10, 2024.
- Both Nasdaq deficiency matters are now closed; no further action required.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844417/000121390024109285/0001213900-24-109285-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844417/000121390024109285/ea0224902-8k_estella.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-109285

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer